ArticleEuropean thyroid journal2025

Authors' reply to letter by Martinod et al. on rationale for using lenvatinib as an urgent initial therapy in thyroid cancer with remarkable laryngotracheal invasion.

Hiroshi Katoh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.